IL162381A0 - A recombinant dna construct and a process for the preparation of a non-toxic anthrax vaccine - Google Patents

A recombinant dna construct and a process for the preparation of a non-toxic anthrax vaccine

Info

Publication number
IL162381A0
IL162381A0 IL16238102A IL16238102A IL162381A0 IL 162381 A0 IL162381 A0 IL 162381A0 IL 16238102 A IL16238102 A IL 16238102A IL 16238102 A IL16238102 A IL 16238102A IL 162381 A0 IL162381 A0 IL 162381A0
Authority
IL
Israel
Prior art keywords
preparation
recombinant dna
dna construct
anthrax vaccine
toxic
Prior art date
Application number
IL16238102A
Other languages
English (en)
Original Assignee
Rakesh Bhatnagar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rakesh Bhatnagar filed Critical Rakesh Bhatnagar
Publication of IL162381A0 publication Critical patent/IL162381A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16238102A 2001-12-05 2002-03-20 A recombinant dna construct and a process for the preparation of a non-toxic anthrax vaccine IL162381A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1222DE2001 2001-12-05
PCT/IN2002/000048 WO2003048390A1 (en) 2001-12-05 2002-03-20 A process for the preparation of a non-toxic anthrax vaccine

Publications (1)

Publication Number Publication Date
IL162381A0 true IL162381A0 (en) 2005-11-20

Family

ID=11097141

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16238102A IL162381A0 (en) 2001-12-05 2002-03-20 A recombinant dna construct and a process for the preparation of a non-toxic anthrax vaccine

Country Status (12)

Country Link
US (1) US7888490B2 (ru)
EP (2) EP1958960A3 (ru)
JP (1) JP2005511059A (ru)
CN (1) CN1694722A (ru)
AU (1) AU2002242935A1 (ru)
BR (1) BRPI0215039A2 (ru)
CA (1) CA2469671A1 (ru)
IL (1) IL162381A0 (ru)
MX (1) MXPA04005538A (ru)
RU (1) RU2287581C2 (ru)
WO (1) WO2003048390A1 (ru)
ZA (1) ZA200404444B (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481043B2 (en) * 2001-06-22 2013-07-09 Cpex Pharmaceuticals, Inc. Nasal immunization
US20060246079A1 (en) * 2003-11-14 2006-11-02 Morrow Phillip R Neutralizing human antibodies to anthrax toxin
WO2005081749A2 (en) * 2004-01-23 2005-09-09 Avanir Pharmaceuticals, Inc. Neutralizing human antibodies to anthraxtoxin
US8409590B2 (en) 2004-02-11 2013-04-02 Ligocyte Pharmaceuticals, Inc. Anthrax antigens and methods of use
EP1954307A4 (en) * 2005-11-14 2009-12-02 Univ Maryland Biotech Inst ORAL VACCINES AGAINST MILZBRAND ON SALMONELLA BASE
CN100362094C (zh) * 2006-02-14 2008-01-16 中国人民解放军军事医学科学院生物工程研究所 一株无pX01和pX02质粒的炭疽杆菌菌株及其用途
GB0607462D0 (en) * 2006-04-13 2006-05-24 Avecia Ltd Assay
CA2651962A1 (en) * 2006-05-12 2007-12-21 Oklahoma Medical Research Foundation Anthrax compositions and methods of use and production
WO2008152655A1 (en) * 2007-06-11 2008-12-18 Panacea Biotec Limited Limited Anthrax fusion proteins, compositions and uses thereof
WO2008152654A1 (en) * 2007-06-11 2008-12-18 Panacea Biotec Limited Anthrax fusion proteins, compositions and uses thereof
CA2738621C (en) 2008-10-02 2017-01-31 Pharmathene Inc. Anthrax vaccine formulation and uses thereof
CN101798565B (zh) * 2010-02-26 2013-08-07 中国人民解放军军事医学科学院生物工程研究所 能在芽孢表面展示pa20蛋白的炭疽芽孢杆菌及其应用
WO2012171329A1 (zh) * 2011-06-15 2012-12-20 Du Quan 一种核酸分离的方法及其应用
CN102516394B (zh) * 2011-12-14 2014-07-09 中国人民解放军军事医学科学院生物工程研究所 CMG2突变体和Fc的融合蛋白及其编码基因与应用
CN105749265B (zh) * 2016-03-30 2020-03-27 中国疾病预防控制中心传染病预防控制所 一种二价炭疽疫苗
CN105797148B (zh) * 2016-03-30 2020-01-14 中国疾病预防控制中心传染病预防控制所 一种无毒炭疽活疫苗及无毒炭疽菌株
CA3165957A1 (en) 2020-01-24 2021-07-29 Thomas K. EQUELS Methods, compositions, and vaccines for treating a virus infection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2017606A (en) 1932-12-24 1935-10-15 Sharp & Dohme Inc Anthrax antigen preparation and product
US2151364A (en) 1937-06-02 1939-03-21 Cutter Lab Anthrax vaccine
RU2115433C1 (ru) 1992-08-28 1998-07-20 Научно-исследовательский институт микробиологии МО РФ Вакцина сибиреязвенная комбинированная
DE69940157D1 (en) 1998-07-10 2009-02-05 U S Medical Res Inst Of Infect Anthrax-impfstoff
FR2798291B1 (fr) * 1999-09-10 2005-01-14 Pasteur Institut Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
US20020051791A1 (en) * 1999-12-22 2002-05-02 Galloway Darrel R. Methods for protection against lethal infection with bacillus anthracis
WO2001082788A2 (en) * 2000-05-04 2001-11-08 President And Fellows Of Harvard College Compounds and methods for the treatment and prevention of bacterial infection
WO2002100340A2 (en) * 2001-06-08 2002-12-19 Avant Immunotherapeutics, Inc. Improved vaccination against anthrax
GB0116798D0 (en) * 2001-07-10 2001-08-29 Secr Defence Expression system
GB0126266D0 (en) * 2001-11-01 2002-01-02 Microbiological Res Authority Anthrax antigenic compositions

Also Published As

Publication number Publication date
US7888490B2 (en) 2011-02-15
CN1694722A (zh) 2005-11-09
RU2287581C2 (ru) 2006-11-20
MXPA04005538A (es) 2005-06-08
WO2003048390A8 (en) 2004-02-05
ZA200404444B (en) 2006-03-29
EP1958960A2 (en) 2008-08-20
JP2005511059A (ja) 2005-04-28
AU2002242935A8 (en) 2003-06-17
US20050063986A1 (en) 2005-03-24
EP1958960A3 (en) 2009-01-07
WO2003048390A1 (en) 2003-06-12
RU2004120293A (ru) 2005-04-20
BRPI0215039A2 (pt) 2016-06-28
AU2002242935A1 (en) 2003-06-17
EP1453534A1 (en) 2004-09-08
CA2469671A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
IL162381A0 (en) A recombinant dna construct and a process for the preparation of a non-toxic anthrax vaccine
HK1077601A1 (zh) 針對人免疫缺陷病毒的遺傳疫苗
EP1383931A4 (en) NUCLEIC ACID VACCINES FOR THE PREVENTION OF FLAVIVIRUS INFECTION
HUP0402471A3 (en) Vaccine
GB0407935D0 (en) Vaccine
HUP0402259A3 (en) Vaccines
EP1421185A4 (en) FAST TIE TEMPERATURE PRESSURE STERILIZATION AND VACCINE MANUFACTURING
HUP0303372A3 (en) Vaccine
EP1423141A4 (en) VACCINE
GB0306611D0 (en) Novel vaccine
GB2393122B (en) Improved vaccination against anthrax
GB0121171D0 (en) Vaccine
EP1429615A4 (en) ORAL VACCINES
EP1490396A4 (en) IMMUNOGENIC HIV PEPTIDES AS REAGENTS AND AS VACCINES
IL145440A0 (en) Synthetic hcv envelope proteins and their use for vaccination
GB0105606D0 (en) Immunogens and vaccines and their preparation and use
AU2002347346A8 (en) Dna vaccine
GB0105238D0 (en) Vaccines
AU2002322013A1 (en) Therapeutic dna vaccination
GB0118475D0 (en) Dna vaccine
AU2002258268A1 (en) Sivmac239 immunogenic plasmids and aids dna vaccine containing the same
GB0100785D0 (en) Nucleic acid vaccine
HU0104622D0 (en) Human influenza vaccine composition with increased activity and process for the preparation thereof
AU2002319485A1 (en) Dna vaccine
GB0129338D0 (en) Vaccination